The American Diabetes Association® (ADA) announces the appointment of David A. D'Alessio, MD, as the incoming Editor in chief of Diabetes®, the ADA's flagship peer-reviewed research journal. Dr. D'Alessio is Professor of Medicine at Duke University, Director of the Division of Endocrinology, and a staff physician at the Durham VA Medical Center. The ADA also announces the appointments of Maureen A. Gannon, PhD, of Vanderbilt University and Norbert Stefan, MD, of Tübingen University as Senior Associate Editors of Diabetes. In addition, the following individuals have been appointed Associate Editors to the editorial team of Diabetes:
• Jonathan Campbell, PhD, of Duke University
• Dawn Belt Davis, MD, PhD, of the University of Wisconsin
• Carmella Evans-Molina, MD, PhD, of Indiana University
• Rana K. Gupta, PhD, of the University of Texas Southwestern Medical Center
• Susan Gurley, MD, PhD, of Oregon Health Sciences University
• Rebecca A. Haeusler, PhD, of Columbia University
• Mark Herman, MD, of Duke University
• David J. Hodson, BVSc (Hons), PhD, FRCVS, of the University of Birmingham (U.K.)
• Daniela Maria Menichella, MD, PhD, of Northwestern University
• Erin Mulvihill, PhD, of the University of Ottawa
• Christopher Newgard, PhD, of Duke University
• Leah Catherine Solberg Woods, PhD, of Wake Forest University
• Jennifer K. Sun, MD, PhD, of Harvard University
• John Ussher, PhD, of the University of Alberta
• C. Bruce Verchere, PhD, of the University of British Columbia
• Kevin W. Williams, PhD, of the University of Texas Southwestern Medical Center
• Daisuke Yabe, MD, PhD, of Gifu University
The incoming editors will serve a three-year term for the 2022–2024 volume years with an optional two-year extension.
In addition to his role as the Professor of Medicine at the Duke University School of Medicine and Director of the Division of Endocrinology, Dr. D'Alessio has consultative practices in the lipid and the endocrinology clinics at Duke Hospital and the Durham VA Medical Center. Dr. D'Alessio went to medical school at the University of Wisconsin, was a resident at Temple University Hospital, and did an endocrinology fellowship at the University of Washington. Dr. D'Alessio has held faculty positions at the University of Washington, University of Cincinnati, and Duke University. His primary research interest is in the regulation of glucose tolerance and abnormalities that lead to type 2 diabetes. Work in his lab focuses on the interplay between circulating glucose, GI hormones, and neural signals to control insulin secretion with a primary focus on the gut peptide GLP-1 and its role in normal physiology, type 2 diabetes, and bariatric surgery. He has research funding from the National Institutes of Health and the Veterans Administration.
"We are thrilled to welcome Dr. D'Alessio as the new Editor in chief of Diabetes," said Dr. Robert Gabbay, Chief Scientific & Medical Officer at the ADA. "We look forward to working with Dr. D'Alessio and his new editorial team on ways to expand the reach and influence of the ground-breaking research published in Diabetes, ADA's flagship research publication."
"Our editorial team is honored to have the opportunity to lead Diabetes for the next few years and enthusiastic about the chance to present the most interesting and relevant new science to the diabetes community," stated Dr. D'Alessio. "We see opportunities to build on the powerful legacy of Diabetes and adapt the reach and impact of the journal in a time or rapidly evolving communication." Dr. D'Alessio and his editorial team will succeed Editor in chief, Martin G. Myers Jr., MD, PhD, and his editorial team, which convened in July 2016. Their term will complete at the end of 2021. Dr. Myers' team includes:
• Karin Bornfeldt, PhD, of the University of Washington
• Frank Brosius, MD, of the University of Arizona
• Charles F. Burant, MD, PhD, of the University of Michigan
• Alessandro Doria, MD, PhD, of the Joslin Diabetes Center, Harvard Medical School
• James Granneman, PhD, Sinai Hospital
• Maria B. Grant, MD, FARVO, of the University of Alabama
• Kevan C. Herold, MD, of Yale University
• Jeffrey F. Horowitz, PhD, of the University of Michigan
• Jiandie D. Lin, PhD, of the University of Michigan
• Carey Nien-Kai Lumeng, MD, PhD, of the University of Michigan
• Ormond A. MacDougald, PhD, of the University of Michigan
• Massimo Pietropaolo, MD, Baylor College of Medicine
• Rodica Pop-Busui, MD, PhD, of the University of Michigan
• Leslie Satin, PhD, of the University of Michigan
• Randy J. Seeley, PhD, of the University of Michigan
• Doris A. Stoffers, MD, PhD, of the University of Pennsylvania
• Qi-Qun Tang, MD, PhD, of the Fudan University Shanghai
• Morris F. White, PhD, Howard Hughes Medical Institute
Drs. D'Alessio, Gannon, and Stefan also served on Dr. Myers' team.
David A. D'Alessio, MD
# # #
,
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For 81 years the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we aim to improve the quality of life for the nearly 122 million Americans living with diabetes or prediabetes. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
